Senescence induces miR‐409 to down‐regulate CCL5 and impairs angiogenesis in endothelial progenitor cells
Journal of Cellular and Molecular Medicine · 2024
DOI: 10.1111/jcmm.18489 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Yen-Hung Chou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, MacKay Medical College, New Taipei, Taiwan. Hauptthemen laut MEDLINE: Cellular Senescence, Chemokine CCL5, Endothelial Progenitor Cells, MicroRNAs. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MacKay Medical College, Institute for Information Industry, Ministry of Science and Technology, Taiwan, MacKay Memorial Hospital.
Abstract (Originalsprache)
This study explores the impact of senescence on autocrine C‐C motif chemokine ligand 5 (CCL5) in human endothelial progenitor cell (EPCs), addressing the poorly understood decline in number and function of EPCs during ageing. We examined the effects of replication‐induced senescence on CCL5/CCL5 receptor (CCR5) signalling and angiogenic activity of EPCs in vitro and in vivo. We also explored microRNAs controlling CCL5 secretion in senescent EPCs, its impact on EPC angiogenic activity, and validated our findings in humans. CCL5 secretion and CCR5 levels in senescent EPCs were reduced, leading to attenuated angiogenic activity. CCL5 enhanced EPC proliferation via the CCR5/AKT/P70S6K axis and increased vascular endothelial growth factor (VEGF) secretion. Up‐regulation of miR‐409 in senescent EPCs resulted in decreased CCL5 secretion, inhibiting the angiogenic activity, though these negative effects were counteracted by the addition of CCL5 and VEGF. In a mouse hind limb ischemia model, CCL5 improved the angiogenic activity of senescent EPCs. Analysis involving 62 healthy donors revealed a negative association between CCL5 levels, age and Framingham Risk Score. These findings propose CCL5 as a potential biomarker for detection of EPC senescence and cardiovascular risk assessment, suggesting its therapeutic potential for age‐related cardiovascular disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, MacKay Medical College, New Taipei, Taiwan.
- Institute of Biomedical Sciences, MacKay Medical College, New Taipei, Taiwan.
- Division of Preventive Cardiology & Pulmonary Circulation Medicine, Department of Cardiovascular Medicine, Department of Internal Medicine and Department of Medical Research, MacKay Memorial Hospital, New Taipei, Taiwan.
ORCID-Profile: Yi-Nan Lee, Cheng-Huang Su
Förderung
- MacKay Medical College
- Institute for Information Industry, Ministry of Science and Technology, Taiwan
- MacKay Memorial Hospital
- National Science and Technology Council
Zitieren
APA
Chou, Y. H., Lee, Y. N., Su, C. H., Lee, H. I., Hsieh, C. L., Tien, T. Y., Lin, C. F., Yeh, H. I., & Wu, Y. J. (2024). Senescence induces miR‐409 to down‐regulate CCL5 and impairs angiogenesis in endothelial progenitor cells. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.18489
Vancouver
Chou YH, Lee YN, Su CH, Lee HI, Hsieh CL, Tien TY, et al. Senescence induces miR‐409 to down‐regulate CCL5 and impairs angiogenesis in endothelial progenitor cells. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.18489
BibTeX
@article{Chou2024,
author = {Chou, Yen-Hung and Lee, Yi-Nan and Su, Cheng-Huang and Lee, Hsin-I and Hsieh, Chin-Ling and Tien, Ting-Yi and Lin, Chao-Feng and Yeh, Hung-I and Wu, Yih-Jer},
title = {Senescence induces miR‐409 to down‐regulate CCL5 and impairs angiogenesis in endothelial progenitor cells},
journal = {Journal of Cellular and Molecular Medicine},
year = {2024},
doi = {10.1111/jcmm.18489}
}
EUVIMED